Pharma in Focus

After conducting an assessment, CSL has pre-empted any result from an ongoing TGA review and withdrawn a troubled drug from the Australian market. To see the whole article, log in or create an account.

Sanofi has dodged a potentially hefty fine after European antitrust regulators accepted a legally-binding commitment by the company to change its tactics, following an investigation into allegations it disparaged a vaccine made by rival CSL Seqirus. To see the whole article, log in or create an account.

After 30 years working in innovative medicine companies, the decision for Nikki Lorenz to become a champion of the generics and biosimilars industry was a surprisingly easy one - and in fact, one that felt like a natural next step in her career. To see the whole article, log in or create an account.

Krystal Biotech is ramping up its Australian commercialisation efforts for Vyjuvek, a topical gene therapy for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB). To see the whole article, log in or create an account.

One year after the late Professor Richard Scolyer challenged Australia to bring the same ambition to brain cancer that helped transform advanced melanoma, advocates returned to Parliament House calling for renewed action. To see the whole article, log in or create an account.

A move to shore up the market of one of the largest drugs in Australia is under threat after overseas jurisdictions put a block on it being produced and sold, ruling it infringed a patent. To see the whole article, log in or create an account.

An independent report launched at Parliament House today highlights how Australia is falling behind in caring for our kids, with more commercial incentives for paediatric medicine needed in the country. To see the whole article, log in or create an account.

Malaria researcher Dr Rhea Longley has won the 2026 Marie Krogh Young Women in Science Prize. To see the whole article, log in or create an account.

GSK executive Andrew Thomas has shared some of the secrets to his success in a new book about how to build a great professional reputation. To see the whole article, log in or create an account.

Talent continues to move across the Australian pharma industry with a string of 'fresh starts' that have included a new role after a redundancy, a move to a new country and the departure from a company after close to two decades. To see the whole article, log in or create an account.